Cargando…
Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
Acute myocardial infarction (AMI) resulting in cardiogenic shock continues to be a substantial source of morbidity and mortality despite advances in recognition and treatment. Prior to the advent of percutaneous and more durable left ventricular support devices, prompt revascularization with the add...
Autores principales: | Dalal, Pratik K., Mertens, Amy, Shah, Dinesh, Hanson, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364115/ https://www.ncbi.nlm.nih.gov/pubmed/30809398 http://dx.doi.org/10.1155/2019/4591250 |
Ejemplares similares
-
Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015) -
Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021) -
The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020) -
Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021) -
Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)